PKC independent inhibition of voltage gated calcium channels by volatile anesthetics in freshly isolated vascular myocytes from the aorta

Cell Calcium

Volumn 54, Issue 4, 2013, Pages 257-265

  Fanchaouy, Mohammed ^a   Cubano, Luis ^a   Maldonado, Hector ^a   Bychkov, Rostislav ^a  

^a SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Halothane; Isoflurane; L type Calcium channels; PKC

Indexed keywords

BARIUM ION; CALCIUM CHANNEL L TYPE; CALCIUM ION; HALOTHANE; ISOFLURANE; PROTEIN KINASE C; VOLTAGE GATED CALCIUM CHANNEL;

AMPLITUDE MODULATION; ANIMAL CELL; AORTA; ARTICLE; CALCIUM CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; INTRACELLULAR SPACE; MALE; MEMBRANE DEPOLARIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE FIBER MEMBRANE POTENTIAL; STEADY STATE;

HALOTHANE; ISOFLURANE; L-TYPE CALCIUM CHANNELS; PKC;

ANESTHETICS, INHALATION; ANIMALS; AORTA; BARIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CELL SEPARATION; GTP-BINDING PROTEINS; HALOTHANE; ION CHANNEL GATING; ISOFLURANE; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN KINASE C; VOLATILIZATION;

EID: 84884281253     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2013.07.001     Document Type: Article

References (64)

1. 2+ stores. Anesthesiology 1994, 80:1120-1127.
2. Su J.Y. Mechanisms of action of isoflurane on contraction of rabbit conduit artery. Anesthesia and Analgesia 1996, 82:837-842.
3. Akata T., Boyle W.A. Dual actions of halothane on intracellular calcium stores of vascular smooth muscle. Anesthesiology 1996, 84:580-595.
4. Vu Huu V., Enoki T., Hirata S., Toda H., Kakuyama M., Nakamura K., Fukuda K. Comparative contractile effects of halothane and sevoflurane in rat aorta. Anesthesiology 2000, 92:219-227.
5. Park K.W., Dai H.B., Lowenstein E., Sellke F.W. Flow-induced dilation of rat coronary microvessels is attenuated by isoflurane but enhanced by halothane. Anesthesiology 1998, 89:132-142.
6. + depolarized rat mesenteric arteries. Anesthesiology 2003, 99:656-665.
7. Ishikawa A., Ogawa K., Tokinaga Y., Uematsu N., Mizumoto K., Hatano Y. The mechanism behind the inhibitory effect of isoflurane on angiotensin II-induced vascular contraction is different from that of sevoflurane. Anesthesia and Analgesia 2007, 105:97-102.
8. Staunton M., Drexler C., Schmid P.G., Havlik H.S., Hudetz A.G., Farber N.E. Neuronal nitric oxide synthase mediates halothane-induced cerebral microvascular dilation. Anesthesiology 2000, 92:125-132.
9. 2+/calmodulin-dependent protein kinase II, and mitogen-activated protein kinases in volatile anesthetic-induced relaxation in newborn rabbit pulmonary artery. Anesthesiology 2003, 99:131-137.
10. Boyle W.A., Maher G.M. Endothelium-independent vasoconstricting and vasodilating actions of halothane on rat mesenteric resistance blood vessels. Anesthesiology 1995, 82:221-235.
11. Su J.Y., Vo A.C. Role of PKC in isoflurane-induced biphasic contraction in skinned pulmonary arterial strips. Anesthesiology 2002, 96:155-161.
12. 2+ channel currents expressed in Xenopus oocytes. Brain Research 1999, 831:85-96.
13. 2+ channels through enhancement of current inactivation. British Journal of Anaesthesia 1999, 82:402-411.
14. Kamatchi G.L., Durieux M.E., Lynch C. Differential sensitivity of expressed L-type calcium channels and muscarinic M1 receptors to volatile anesthetics in Xenopus oocytes. Journal of Pharmacology and Experimental Therapeutics 2001, 297:981-990.
15. Milnor W.R. Aortic wavelength as a determinant of the relation between heart rate and body size in mammals. American Journal of Physiology 1979, 237:3-6.
16. Milnor W.R. Arterial impedance as ventricular afterload. Circulation Research 1975, 36:565-570.
17. Flewitt J.A., Hobson T.N., Wang J., Johnston C.R., Shrive N.G., Belenkie I., Parker K.H., Tyberg J.V. Wave intensity analysis of left ventricular filling: application of Windkessel theory. American Journal of Physiology: Heart and Circulatory Physiology 2007, 292:H2817-H2823.
18. Baselli G., Porta A., Pagani M. Coupling arterial windkessel with peripheral vasomotion: modeling the effects on low-frequency oscillations. IEEE Transactions on Biomedical Engineering 2006, 53:53-64.
19. Hayoz S., Bény J.L., Bychkov R. Intracellular cAMP: the switch that triggers on spontaneous transient outward currents generation in freshly isolated myocytes from thoracic aorta. American Journal of Physiology: Cell Physiology 2007, 292:C1502-C1509.
20. 2+-dependent currents in freshly isolated aortic smooth muscle cells. Cell Calcium 2005, 37:25-34.
21. 2+ current and transient outward K+ current in subendocardial and subepicardial myocytes from the rat left ventricle. Anesthesia and Analgesia 2004, 99:1615-1622.
22. Franks N.P., Lieb W.R. Temperature dependence of the potency of volatile general anesthetics. Anesthesiology 1996, 84:716-720.
23. Harrison S.M., Robinson M., Davies L.A., et al. Mechanisms underlying the inotropic action of halothane on intact rat ventricular myocytes. British Journal of Anaesthesia 1999, 82:609-721.
24. Fang H., Huang Y., Zuo Z. The different responses of rat glutamate transporter type 2 and its mutant (tyrosine 403 to histidine) activity to volatile anesthetics and activation of protein kinase C. Brain Research 2002, 953:255-264.
25. Gomez R.S., Barbosa J., Guatimosim C., Massensini A.R., Gomez M.V., Prado M.A. Translocation of protein kinase C by halothane in cholinergic cells. Brain Research Bulletin 2002, 58:55-59.
26. Styer A.M., Mirshahi U.L., Wang C., Girard L., Jin T., Logothetis D.E., Mirshahi T. G protein {beta}{gamma} gating confers volatile anesthetic inhibition to Kir3 channels. Journal of Biological Chemistry 2010, 285:41290-41299.
27. Pusch M., Neher E. Rates of diffusional exchange between small cells and a measuring patch pipette. Pflügers Archiv 1988, 411:204-211.
28. 2+ channel and its modulation by protein kinase C. Journal of Biological Chemistry 1998, 273:17901-17909.
29. 2+ channel. FEBS Letters 1995, 377:159-162.
30. 2+ channels in Xenopus oocytes by protein kinase C. FEBS Letters 1992, 306:113-118.
31. McHugh D., Sharp E.M., Scheuer T., Catterall W.A. Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:12334-12338.
32. He J.Q., Pi Y., Walker J.W., Kamp T.J. Endothelin-1 and photoreleased diacylglycerol increase L-type Ca21 current by activation of protein kinase C in rat ventricular myocytes. Journal of Physiology 2000, 524:807-820.
33. 2+ channels. Circulation Research 1997, 80:720-729.
34. Obejero-Paz C.A., Auslender M., Scarpa A. PKC activity modulates availability and long openings of L-type Ca21 channels in A7r5 cells. American Journal of Physiology: Cell Physiology 1998, 275:C535-C543.
35. 2+ channels in human vascular smooth muscle. FEBS Letters 1994, 341:208-212.
36. Viard P., Exner T., Maier U., Mironneau J., Nurnberg B., Macrez N. Gbg dimers stimulate vascular L-type Ca2+ channels via phosphoinositide 3-kinase. FASEB Journal 1999, 13:685-694.
37. 2+ channel current in guinea-pig myocytes. Journal of Physiology 1996, 494:91-103.
38. Bosnjak Z.J., Supan F.D., Rusch N.J. The effects of halothane, enflurane, and isoflurane on calcium current in isolated canine ventricular cells. Anesthesiology 1991, 74:340-345.
39. Eskinder H., Rusch N.J., Supan F.D., Kampine J.P., Bosnjak Z.J. The effects of volatile anesthetics on L- and T-type calcium channel currents in canine cardiac Purkinje cells. Anesthesiology 1991, 74:919-926.
40. 2+ channels expressed in HEK-293 cells. Anesthesiology 2005, 103:1156-1166.
41. Zahradník I., Minarovic I., Zahradníková A. Inhibition of the cardiac L-type calcium channel current by antidepressant drugs. Journal of Pharmacology and Experimental Therapeutics 2008, 324:977-984.
42. 2+ currents in neonatal mouse inner hair cells. European Journal of Pharmacology 2007, 573:39-48.
43. Hockerman G.H., Dilmac N., Scheuer T., Catterall W.A. Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca(2+) channels. Molecular Pharmacology 2000, 58:1264-1270.
44. Sasaki T., Nakatani Y., Sugiyama K. The inhibitory effect of nilvadipine on calcium channels in retinal ganglion cells in goldfish. Journal of Ocular Pharmacology and Therapeutics 2006, 22:455-459.
45. Drígelová M., Tarabová B., Duburs G., Lacinová L. The dihydropyridine analogue cerebrocrast blocks both T-type and L-type calcium currents. Canadian Journal of Physiology and Pharmacology 2009, 87:923-932.
46. Wu B.N., Chen M.L., Dai Z.K., Lin Y.L., Yeh J.L., Wu J.R., Chen I.J. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells. Vascular Pharmacology 2009, 51:65-71.
47. 2+ channel modulator, in rat ventricular myocytes. Clinical and Experimental Pharmacology and Physiology 2010, 37:817-825.
48. Liao P., Yu D., Li G., Yong T.F., Soon J.L., Chua Y.L., Soong T.W. A smooth muscle Cav1.2 calcium channel splice variant underlies hyperpolarized window current and enhanced state-dependent inhibition by nifedipine. Journal of Biological Chemistry 2007, 282:35133-35142.
49. Freeze B.S., McNulty M.M., Hanck D.A. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel. Molecular Pharmacology 2006, 70:718-726.
50. 2+ channel in its open state. Channels (Austin) 2011, 5:482-488.
51. Lacinová L. Voltage-dependent calcium channels. General Physiology and Biophysics 2005, 1:1-78.
52. 2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive. European Journal of Pharmacology 2011, 670:105-113.
53. Park W.K., Pancrazio J.J., Suh C.K., Lynch C. Myocardial depressant effects of sevoflurane. Mechanical and electrophysiologic actions in vitro. Anesthesiology 1996, 84:1166-1176.
54. Camara A.K., Begic Z., Kwok W.M., Bosnjak Z.J. Differential modulation of the cardiac L- and T-type calcium channel currents by isoflurane. Anesthesiology 2001, 95:515-524.
55. Schmidt U., Schwinger R.H., Bohm M. Interaction of halothane with inhibitory G-proteins in the human myocardium. Anesthesiology 1995, 83:353-360.
56. Minami K., Sudo Y., Yokoyama T., Ogata J., Takeuchi M., Uezono Y. Sevoflurane inhibits the μ-opioid receptor function expressed in Xenopus oocytes. Pharmacology 2011, 88:127-132.
57. 2+channels (CaV1.2a,b) by protein kinases. American Journal of Physiology: Cell Physiology 2001, 281:C1743-C1756.
58. 2+ channel current by phorbol esters. American Journal of Physiology 1996, 270:H620-H627.
59. Bourinet E., Fournier F., Lory P., Charnet P., Nargeot J. Protein kinase C regulation of cardiac calcium channels expressed in Xenopus oocytes. Pflügers Archiv 1992, 421:247-255.
60. 2+ channel: perspectives for new pharmacological targets. Journal of Pharmacology and Experimental Therapeutics 2002, 30072:4-8.
61. Bannister J.P., Thomas-Gatewood C.M., Neeb Z.P., Adebiyi A., Cheng X., Jaggar J.H. Ca(V)1.2 channel N-terminal splice variants modulate functional surface expression in resistance size artery smooth muscle cells. Journal of Biological Chemistry 2011, 286.
62. Cheng R.C., Tikhonov D.B., Zhorov B.S. Structural model for phenylalkylamine binding to L-type calcium channels. Journal of Biological Chemistry 2009, 284:28332-28342.
63. Terrar D.A., Victory J.G. Effects of halothane on membrane currents associated with contraction in single myocytes isolated from guinea-pig ventricle. British Journal of Pharmacology 1988, 94:500-508.
64. Cafiso D.S. Dipole potentials and spontaneous curvature: membrane properties that could mediate anesthesia. Toxicology Letters 1998, 101:431-439.